These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 6332794)

  • 21. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
    J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sleep-promoting effects of muramyl peptides.
    Krueger JM; Pappenheimer JR; Karnovsky ML
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6102-6. PubMed ID: 6964403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muramyl dipeptide-induced sleep and fever: effects of ambient temperature and time of injections.
    Shoham S; Krueger JM
    Am J Physiol; 1988 Jul; 255(1 Pt 2):R157-65. PubMed ID: 3394839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muramyl dipeptide enhances in vitro peritoneal macrophage phagocytic activity.
    McCoy DM; Brown GL; Ausobsky JR; Polk HC
    Am Surg; 1985 Nov; 51(11):634-6. PubMed ID: 4062058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of muramyl peptides on macrophages, monokines, and sleep.
    Pabst MJ; Beranova-Giorgianni S; Krueger JM
    Neuroimmunomodulation; 1999; 6(4):261-83. PubMed ID: 10393513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of colony-stimulating factor from macrophages by muroctasin.
    Yamaguchi F; Akahane K; Takashi T; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muramyl dipeptide, amphetamine, and physostigmine: effects on sleep of rabbits.
    Shoham S; Davenne D; Krueger JM
    Physiol Behav; 1987; 41(2):179-85. PubMed ID: 3685166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muramyl peptides. Variation of somnogenic activity with structure.
    Krueger JM; Walter J; Karnovsky ML; Chedid L; Choay JP; Lefrancier P; Lederer E
    J Exp Med; 1984 Jan; 159(1):68-76. PubMed ID: 6693833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in vivo effect of cyclosporine A on macrophages.
    Matsushima Y; Baba T
    J Exp Pathol; 1990; 5(2):39-48. PubMed ID: 2090798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-1-induced sleep and febrile responses differentially altered by a muramyl dipeptide derivative.
    Cady AB; Riveau G; Chedid L; Dinarello CA; Johannsen L; Krueger JM
    Int J Immunopharmacol; 1989; 11(8):887-93. PubMed ID: 2613394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
    Daemen T; Veninga A; Roerdink FH; Scherphof GL
    Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
    Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
    J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muramyl peptides in mammalian tissues and their effects at the cellular level.
    Karnovsky ML
    Fed Proc; 1986 Oct; 45(11):2556-60. PubMed ID: 3758374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An interleukin-1 receptor fragment inhibits spontaneous sleep and muramyl dipeptide-induced sleep in rabbits.
    Takahashi S; Kapás L; Fang J; Seyer JM; Wang Y; Krueger JM
    Am J Physiol; 1996 Jul; 271(1 Pt 2):R101-8. PubMed ID: 8760209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.
    Phillips NC; Moras ML; Chedid L; Lefrancier P; Bernard JM
    Cancer Res; 1985 Jan; 45(1):128-34. PubMed ID: 3838084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
    Sarkar K; Das PK
    J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muramyl dipeptide and mononuclear cell supernatant induce Langhans-type cells from human monocytes.
    Mizuno K; Okamoto H; Horio T
    J Leukoc Biol; 2001 Sep; 70(3):386-94. PubMed ID: 11527988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of macrophage cytostatic and cytotoxic activity in vitro by liposomes containing a new lipophilic muramyl peptide derivative, MDP-L-alanyl-cholesterol (MTP-CHOL).
    Phillips NC; Moras ML; Chedid L; Petit JF; Tenu JP; Lederer E; Bernard JM; Lefrancier P
    J Biol Response Mod; 1985 Oct; 4(5):464-74. PubMed ID: 3935756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipophilic muramyl dipeptide-induced changes in electron microscopic morphology and phagocytic function of murine macrophages.
    Masihi KN; Ozel M; Lange W; Azuma I
    J Biol Response Mod; 1986 Feb; 5(1):20-6. PubMed ID: 3958752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of differentiation-stimulating factor for murine leukemic myeloblast line by monocytic cells stimulated by a nonpyrogenic muramyl dipeptide derivative.
    Parant M; Vinit MA; Damais C; Riveau G; Chedid L
    Exp Hematol; 1985 Mar; 13(3):221-8. PubMed ID: 3872225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.